Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Invyncible vs Liberty

Invyncible
Graded #303

Level

vs
Liberty
Graded #304

Level

The verdict

Too close to call — both grade 61/100 (C).

Invyncible and Liberty land on the same WeighScore, so neither clears the other on our six graded dimensions. Invyncible sits one line higher on the board (#303 vs #304) on the underlying tiebreak, but it's a genuine coin-flip — pick on the factors and prices that matter most to you below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueInvyncible +11
55
44
Dose & formulationLiberty +13
64
77
Clinical oversightLiberty +6
70
76
Labs & monitoringLiberty +2
52
54
FulfillmentLiberty +16
65
81
Contract termsInvyncible +41
61
20
Invyncible · left barLiberty · right bar

The numbers

MetricInvyncibleLiberty
WeighScore61/10061/100
GradeCC
Scorecard rank#303#304
Semaglutide$192/mo (0.5 mg dose, compounded)$199/mo (compounded)
Tirzepatide$210/mo (compounded)$299/mo (compounded)
Coverage40 statesCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
Invyncible

Graded #303 · C

Strengths

  • Corporate parent disclosed (Nationwide Telemedicine, LLC) — better than most competitors hiding behind trade names
  • Physical corporate address published (St. Petersburg, FL)
  • LegitScript verification seal displayed
  • No long-term commitment required
  • Offers both semaglutide and tirzepatide programs

Where it loses points

  • Pricing not disclosed on the public site — fully gated behind signup
  • Drug forms (compounded vs brand, injection vs oral) not disclosed
  • 503A vs 503B designation not specified
  • Pharmacy partner not named
  • States served not listed publicly
Liberty

Graded #304 · C

Strengths

  • Compounded GLP-1 sourced from FDA-registered 503B outsourcing facilities, a stricter standard than the 503A pharmacies many competitors use
  • Transparent flat pricing: compounded semaglutide $199/mo (about $171/mo on a 3-month supply) and tirzepatide $299/mo
  • Nationwide in all 50 states with free discreet shipping, 24/7 support, and FSA/HSA acceptance
  • Multi-vertical menu beyond weight loss (low-dose microdosing, NAD+, sermorelin, metformin) for patients who want bundled wellness care

Where it loses points

  • Does not name its specific compounding pharmacy partner, only that it is a 503B facility
  • Tirzepatide at $299/mo is mid-market rather than the cheapest option among compounded providers
  • Generic corporate branding (Liberty Health) with limited public detail on the operating entity
  • Compounded medication only — no brand-name or insurance-covered GLP-1 path

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard